Abstract
Aims :
To assess and compare the activity of pharmaceutical analysis on drug
management in a geriatric acute care unit prior to and during the
COVID-19 pandemic.
Methods :
This was a single-centre, observational, retrospective, and comparative
cohort study. All Pharmacist Interventions (PIs) carried out in the unit
between 27 January 2020 and 30 April 2020 were distinguished according
to whether they were conducted prior to or during the first wave of
COVID-19.
The main outcome measure was the rate of PIs per patient and per line of
treatment analysed. Other data collected were the drug class managed by
the PI, the Drug Related Problems (DRP) identified, the nature of the
advice given, and the acceptance rate by geriatricians.